🍂 Enjoy the Fall Season! 🍂
MindTheDesk

Personalized Cancer Vaccine Shows Promise In Major Trial

Top Story Archived • October 24, 2026 •
Personalized Cancer Vaccine Shows Promise In Major Trial
Pharmaceutical companies Merck and Moderna reported that an experimental personalized mRNA vaccine, given alongside the immunotherapy drug Keytruda, reduced the risk of melanoma recurrence or death by 42% compared with Keytruda alone.   The Phase 3 trial included 1,137 patients with Stage IIB-IV melanoma whose tumors had been surgically removed. The findings could bring the drugmakers ...
Source: Daily Wire | https://www.dailywire.com/feeds/rss.xml - Read Original
"Output is a realization of Input."
"Retirement Health Care"

Discussion (0)

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!

Sponsored